News
Recent publications by the MyPeBS team
We are proud to share these recent relevant publications by the teams involved in MyPeBS consortium Harry de Koning and team (lead WP4 of MyPeBS) have recently published in the New England Journal of Medicine the final (and very expected) results of the NELSON trial,...
Envision network consensus statement
The MyPeBS consortium is proud to announce the publication of the Envision network consensus statement on personalized early detection and prevention of breast cancer. MyPeBS is one of the 5 founders of the ENVISION initiative Summary of the paper: “The European...
2nd International DKFZ Conference on Cancer Prevention – Virtual Meeting – September 17 – 18, 2020
Primary Cancer Prevention Research in risk factors aiming for practical interventions Cancer Prevention in Europe Secondary Cancer Prevention Precision Prevention Prostate and Breast Cancer Screening Tertiary Cancer Prevention Improving life with and after cancer...
Response to the “open letter” of several anti-screening collectives
Four anti-screening collectives located in France, Italy, Belgium, and the United Kingdom recently published an "open letter" questioning the methodology and ethics of the MyPeBS study. Find here the answers of Dr Suzette Delaloge, MyPeBS Coordinating Investigator....
Participation of MyPeBS team in the first edition of ENVISION
The first European conference on risk-stratified prevention and early detection of breast cancer was held from 26 to 28 June 2019 in Austria. The main objective was to pool knowledge and set actions towards implementation of risk-based breast cancer prevention and...
313 single nucleotide polymorphisms contribute to predict individual breast cancer risk
A woman’s risk of breast cancer is affected by her genetic make up. Some bits of the normal genetic material (DNA) differs between one person and another: they are known as single nucleotide polymorphisms or SNPs. Different combinations of these SNPs are associated...
ICPV, a voice with MyPeBS
Independent Cancer Patients’ Voice (ICPV) is one of the partners of the MyPeBS consortium. Two of their members, Emse and Debbie, made a statement on why MyPeBS study is so important to them: “As patients with lived experience of breast cancer (one of us diagnosed at...
MyPeBS trial launch consortium meeting
Almost 100 partners as well as stakeholders of the project met in Paris on September 28th 2018 to prepare the launch of the MyPeBS clinical trial. It was the opportunity for all participants to get practical information on all operational aspects of the clinical...
MyPeBS Project Kick off meeting
All partners got together in Paris, on January 12th2018 for the first consortium meeting, to launch the MyPeBS project. Organizational and conceptual issues were discussed regarding the project and the clinical trial. This meeting also was the opportunity for many of...